1.
Oğul A, Büyükşimşek M. Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy. Med Sci Discov [Internet]. 2020May2 [cited 2020Jul.11];7(5):475-81. Available from: https://medscidiscovery.com/index.php/msd/article/view/374